BFC Planning’s Voyager Therapeutics VYGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.7K Hold
4,000
– – ﹤0.01% 2347
2026
Q2
$14K Hold
4,000
– – ﹤0.01% 2192
2026
Q1
$15.4K Hold
4,000
– – ﹤0.01% 1832
2025
Q4
$15.7K Hold
4,000
– – ﹤0.01% 1853
2025
Q3
$18.7K Buy
+4,000
New +$14.5K ﹤0.01% 1610

Other funds holding VYGR

BFC Planning's VYGR Position: Q3 2026 in Review

BFC Planning held its Voyager Therapeutics (VYGR) position steady in Q3 2026 at 4,000 shares worth $10.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2347.

BFC Planning first reported a position in VYGR in Q3 2025 and has held it in 5 quarters since. The position peaked at $18.7K in Q3 2025. 83 funds tracked by Wall St. Rank hold VYGR as of Q3 2026.

  • BFC Planning held 4,000 shares of Voyager Therapeutics worth $10.7K as of Q3 2026.
  • BFC Planning left its Voyager Therapeutics share count unchanged in Q3 2026.
  • Voyager Therapeutics made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2347 holding.
  • BFC Planning first reported a position in Voyager Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • BFC Planning's Voyager Therapeutics position peaked at $18.7K in Q3 2025.
  • 83 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.